Cellulitis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections; Skin and Connective Tissue Diseases
|
Pathologic Function
|
38
|
1
|
0.100 |
None |
|
0 |
|
|
|
Hepatosplenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Hemic and Lymphatic Diseases
|
Sign or Symptom
|
127
|
21
|
0.100 |
None |
|
0 |
1
|
|
|
Splenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
345
|
19
|
0.100 |
None |
|
0 |
|
|
|
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.100 |
None |
|
0 |
1
|
|
|
Recurrent ear infections
|
group |
|
Finding
|
11
|
1
|
0.100 |
None |
|
0 |
|
|
|
Recurrent sinopulmonary infections
|
phenotype |
|
Finding
|
16
|
|
0.100 |
None |
|
0 |
|
|
|
T-Lymphocytopenia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Specific pneumococcal antibody deficiency
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Increased proportion of transitional B cells
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased proportion of class-switched memory B cells
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Fibroid Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
413
|
14
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |
Synovitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
197
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Skin carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
136
|
24
|
0.010 |
None |
< 0.001 |
1 |
|
2010 |
2010 |
early pregnancy
|
phenotype |
|
Disease or Syndrome
|
273
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Advanced lung cancer
|
disease |
|
Neoplastic Process
|
59
|
9
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.020 |
None |
0.500 |
2 |
|
2005 |
2019 |
Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2018 |
Carcinoma, Transitional Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
623
|
12
|
0.050 |
None |
0.600 |
5 |
|
2009 |
2018 |
Urothelial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
449
|
10
|
0.050 |
None |
0.600 |
5 |
|
2009 |
2018 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.030 |
None |
0.667 |
3 |
|
2019 |
2020 |
Resistance to Insulin-Like Growth Factor I
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
55
|
4
|
0.030 |
None |
0.667 |
3 |
|
2017 |
2019 |
Multiple Chronic Conditions
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
929
|
42
|
0.030 |
None |
0.667 |
3 |
|
2017 |
2018 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.040 |
None |
0.750 |
4 |
|
2010 |
2019 |
Influenza
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
858
|
17
|
0.040 |
None |
0.750 |
4 |
|
2007 |
2019 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
478
|
23
|
0.050 |
None |
0.800 |
5 |
|
2013 |
2018 |